FDA.reportPublic FDA data

palovarotene 5 MG Oral Capsule

RxCUI
2663980
RxNorm name
palovarotene 5 MG Oral Capsule
Display name
palovarotene 5 MG Oral Capsule
Full name
palovarotene 5 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
67dce406-7cc4-4d66-92de-ad18b6df0625palovarotene 5 MG Oral Capsule [PSN] · palovarotene 5 MG Oral Capsule [SCD] · palovarotene 5 MG Oral Capsule [SY]32These highlights do not include all the information needed to use SOHONOS ® safely and effectively. See full prescribing information for SOHONOS. SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 202320250318